xiapex: Clinical Trials

19 trials of xiapex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 1 active not recruiting, 1 unknown. 6 Phase 3, 5 Phase 2, 4 Phase 4, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 25Completed 5
Phase 44Completed 2, Active not recruiting 1, Unknown 1
Not applicable1Completed 1
Phase 11Completed 1

Follow xiapex: new trials by email Literature Review of xiapex trials Research Report on xiapex

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial Comparing Treatment Strategies in Dupuytren's Contracture
Percutaneous needle fasciotomy (PNF), Collagenase Clostridium Histolyticum (CCH) 2.9 MG/ML [Xiaflex], Limited fasciectomy (LF) - Dupuytren Contracture
Phase 4Active not recruitingTampere University3022017-09-152026-04-29
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
Xiapex - Dupuytren Contracture
CompletedJeppe Lange1992017-01-012020-04-22
Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture
xiapex, percutaneous needle fasciotomy - Dupuytrens Contracture
Phase 4UnknownOslo University Hospital502015-04-012015-06-19
An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease
AA4500, ErecAid® Esteem® Manual Vacuum Therapy System, Investigator Modeling - Peyronie's Disease
Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company302014-10-012017-11-08
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
Collagenase clostridium histolyticum, Placebo - Dupuytren's Disease
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company762014-07-012017-10-05
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
Collagenase Clostridium Histolyticum, Placebo - Adhesive Capsulitis, Frozen Shoulder
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company3222013-11-012017-10-05
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
Xiapex, Needle aponeurotomy - Dupuytren Contracture
Phase 4CompletedUniversity Hospital, Akershus802013-10-012022-04-26
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Collagenase Clostridium Histolyticum, Placebo - Edematous Fibrosclerotic Panniculopathy (EFP)
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company1502013-10-012017-10-05
Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures
XIAFLEX / XIAPEX - Dupuytren's Contracture
Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company7152012-09-012017-10-05
A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease
AA4500 - Peyronie's Disease
Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company1892012-09-012017-10-05
Collagenase Option for Reduction of Dupuytren's Contracture in Japan
Collagenase Clostridium Histolyticum - Dupuytren's Contracture
Phase 3CompletedAsahi Kasei Therapeutics Corporation1042012-05-012017-03-21
Retreatment of Recurrent Dupuytren's Contractures
Collagenase clostridium histolyticum - Dupuytren's Disease
Phase 4CompletedEndo USA Inc., a Keenova Therapeutics Company522012-03-012017-10-05
Post Approval Commitment Study
Xiapex, surgery - Dupuytren's Contracture
CompletedEndo USA Inc., a Keenova Therapeutics Company3052012-03-012017-10-26
Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture
Xiapex, Percutaneous needle fasciotomy - Dupuytrens Contracture
Not applicableCompletedJeppe Lange, MD502012-02-012016-10-04
The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM - Edematous Fibrosclerotic Panniculopathy, Cellulite
Phase 1CompletedEndo USA Inc., a Keenova Therapeutics Company992012-01-012015-03-19
AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
AA4500 0.29 mg/1 mL, AA4500 0.58 mg/2 mL, AA4500 0.58 mg/1 mL - Adhesive Capsulitis, Frozen Shoulder
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company502011-11-012017-10-05
Administration of Two Injections for Multiple Dupuytren's Contractures
AA4500 collagenase clostridium histolyticum - Dupuytren's Contracture
Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company602011-09-012017-10-05
Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease
AA4500 - Peyronie's Disease
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company202011-09-012017-10-05
Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)
Xiapex - Dupuytren's Contracture
Phase 3CompletedPfizer2542010-12-012014-03-17

Conditions studied

Dupuytren Contracture (12)  ·  Contracture (3)  ·  Penile Induration (3)  ·  Bursitis (2)  ·  Cellulite (2)  ·  Connective Tissue Diseases (1)  ·  Shoulder Pain (1)

Sponsors

Endo USA Inc., a Keenova Therapeutics Company (12)  ·  Asahi Kasei Therapeutics Corporation (1)  ·  Jeppe Lange (1)  ·  Jeppe Lange, MD (1)  ·  Oslo University Hospital (1)  ·  Pfizer (1)  ·  Tampere University (1)  ·  University Hospital, Akershus (1)

Countries

United States (9)  ·  Australia (4)  ·  Norway (3)  ·  United Kingdom (3)  ·  Denmark (2)  ·  Spain (2)  ·  Sweden (2)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)

Top investigators

Veronica Urdaneta, MD MPH (3)  ·  Veronica Urdaneta, MD, MPPH (3)  ·  Aleksi RP Reito, M.D., Ph.D., adjunct professor (1)  ·  Antti OV Malmivaara, M.D., Ph.D., adjunct professor (1)  ·  Charlotte Hartig-Andreasen, MD, PhD (1)  ·  Gregory J. Kaufman, MD (1)  ·  Gregory Kaufman, MD (1)  ·  Hannu Kautiainen, MSc (1)  ·  Jeppe Lange, M.D. (1)  ·  Neil H Schusterman, MD FACP (1)  ·  Neil H Shusterman, MD FACP (1)  ·  Neil Shusterman, MD (1)  ·  Per-Henrik Randsborg, PhD (1)

Results publications

PMID 24470559, PMID 27313184, PMID 28854973, PMID 28974406, PMID 30722822, PMID 38346307, PMID 41334972